What other countries could teach the U.S. about bringing down drug prices
Last year, Kevin Schulman, a health economist at Stanford Graduate School of Business and Stanford School of Medicine, taught a course on health information technology and strategy. Sitting in on the class was Iselin Dahlen Syversen, the head of the …